Companies/IMRIS Inc.

Company profile

IMRIS Inc.

OTC: IMRSQ · Healthcare · Medical - Specialties

Canadian filerReports USD

#503 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 26

v0.1 · 5/100 weight · pillars only

↑ workforce scale, growth stability · ↓ market scale, listing tenure

Methodology →

Revenue TTM

$28.9M

Rev growth YoY (TTM)

-37.3%

Net income (FY)

-$30.4M

Employees

121

Market cap

$626

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$28.9M$28.9M2014

Net income-$30.4M-$30.4M2014

Operating income-$23.1M-$23.1M2014

Total assets$65.5M$65.5M2014

Liabilities$53.7M$53.7M2014

Equity$11.8M$11.8M2014

Revenue trend

FY2007 – FY2014 · USD

$17.6M

FY07

$18.9M

FY08

$42.4M

FY09

$70.3M

FY10

$51.8M

FY11

$52.4M

FY12

$46.0M

FY13

$28.9M

FY14

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

IMRIS Inc. booked $28.9M in FY2014 revenue, contracting 37% year over year — slower than 79% of Healthcare companies we track, at a -105.2% net margin.

Peers · Healthcare

North Bud Farms Inc.——Motus GI Holdings, Inc.——OncoSec Medical Incorporated——Interpharm Holdings, Inc.——

Key facts

CEOShalabh Chandra

SectorHealthcare

IndustryMedical - Specialties

Headquarters—

ExchangeOTC: IMRSQ

Employees121

IPO date2023-01-20

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.